Filing Flows › AstraZeneca (AZN) › Operating margin
AstraZeneca (AZN) operating margin by quarter
AstraZeneca's operating margin was 27.1% in Q3 2026 (third quarter 2026), +6.5 pts from Q2 2026. Over the last 5 quarters it ranged from 20.6% (Q2 2026) to 27.8% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 27.1% | +6.5 pts | +3.5 pts |
| Q2 2026 | 20.6% | -7.2 pts | -3.7 pts |
| Q1 2026 | 27.8% | +4.2 pts | — |
| Q3 2025 | 23.6% | -0.7 pts | — |
| Q2 2025 | 24.3% | — | — |
Q3 2026 at a glance
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is AstraZeneca's operating margin?
AstraZeneca's operating margin was 27.1% in Q3 2026 (third quarter 2026), +6.5 pts from Q2 2026.
How has AstraZeneca's operating margin changed?
Over the last 5 quarters it ranged from 20.6% (Q2 2026) to 27.8% (Q1 2026).